Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Higher doses of isotretinoin may lead to more hair loss.

Tofacitinib helped regrow hair in a lupus patient with alopecia.

Underactive bladder is hard to diagnose and treat, needing more research.

Ritlecitinib is effective and safe for hair regrowth in Asian patients with alopecia areata.

Experts recommend personalized treatment plans for alopecia areata, using corticosteroids and minoxidil for mild cases, and stronger medications for severe cases.

Ritlecitinib is safe and may effectively treat alopecia areata.

Hyaluronic acid fillers for temporal lifting can cause hair loss without scarring.

Prostate cancer patients need early psychological and sexual support during radiotherapy to improve their quality of life.

Reflectance confocal microscopy is useful for diagnosing and monitoring skin diseases, but it has limitations and requires expertise for correct use.

Cannabinoids like CBD and THC may help treat non-cancer skin diseases, but more research is needed.

The pandemic changed the types of skin conditions seen, not the number of visits.

Aloe vera is effective for healing, skin, and health due to its beneficial compounds.

COVID-19 can worsen autoimmune skin diseases and increase their occurrence.

The document suggests a new way to categorize skin and mind disorders into two main groups to reduce confusion.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

People living with HIV in Turkey often have skin conditions, which are more common in advanced HIV stages and may help in diagnosing the infection.

Botulinum toxins are safe for various medical and cosmetic uses, but more research is needed for long-term safety and effectiveness in hair growth treatments.

Tofacitinib effectively treated both ulcerative colitis and alopecia areata in two patients.

Ruxolitinib can cause a delayed skin reaction on the nose.

A woman with vitiligo had a rare fungal infection around her vitiligo patch and it improved with antifungal cream.

Managing stress and nerve activity can help treat segmental vitiligo and white hair.

Baricitinib is effective and safe for treating alopecia areata in Korea.

JAK inhibitors show promise for treating various skin diseases.

About a quarter of the participants experienced hair loss after COVID-19 vaccination.

PRP use in skin care and plastic surgery is growing, especially in the U.S. and Italy.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.